94 related articles for article (PubMed ID: 12957355)
1. TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
Lee SJ; Ohashi Y; Sakurai H; Saiki I
Cancer Lett; 2003 Aug; 198(2):169-77. PubMed ID: 12957355
[TBL] [Abstract][Full Text] [Related]
2. TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.
Murakami K; Yamaura T; Suda K; Ohie S; Shibata J; Toko T; Yamada Y; Saiki I
Jpn J Cancer Res; 1999 Nov; 90(11):1254-61. PubMed ID: 10622538
[TBL] [Abstract][Full Text] [Related]
3. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.
Murakami K; Matsuura T; Sano M; Hashimoto A; Yonekura K; Sakukawa R; Yamada Y; Saiki I
Clin Exp Metastasis; 1998 Oct; 16(7):633-43. PubMed ID: 9932610
[TBL] [Abstract][Full Text] [Related]
4. Contribution of AP-1 interference induced by TAC-101 to tumor growth suppression in a hepatocellular carcinoma model.
Eshima K; Fukaya S; Sugimoto A; Mori T; Yokoi H; Yamamoto Y; Sugiura S; Honda S; Masuko N; Murakami K; Yamasaki Y; Kagechika H
Tumour Biol; 2009; 30(1):1-7. PubMed ID: 19142034
[TBL] [Abstract][Full Text] [Related]
5. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expression.
Sako T; Nakayama Y; Minagawa N; Inoue Y; Onitsuka K; Katsuki T; Tsurudome Y; Shibao K; Hirata K; Nagata N; Ohie S; Kohno K; Itoh H
In Vivo; 2005; 19(1):125-32. PubMed ID: 15796164
[TBL] [Abstract][Full Text] [Related]
6. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
Sakukawa R; Murakami K; Ikeda T; Yamada Y; Saiki I
Oncol Res; 1998; 10(6):287-93. PubMed ID: 9848099
[TBL] [Abstract][Full Text] [Related]
7. The induction of apoptosis and inhibition of AP-1 activity by TAC-101 (4-[3,5-bis(trimethylsilyl) benzamido] benzoic acid) may result in life prolonging effect in animals bearing metastasizing cancer.
Shibata J; Murakami K; Aoyagi Y; Oie S; Hashimoto A; Suzuki K; Sano M; Wierzba TT; Yamada Y
Anticancer Res; 2000; 20(5B):3583-90. PubMed ID: 11131666
[TBL] [Abstract][Full Text] [Related]
8. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span.
Murakami K; Wierzba K; Sano M; Shibata J; Yonekura K; Hashimoto A; Sato K; Yamada Y
Clin Exp Metastasis; 1998 May; 16(4):323-31. PubMed ID: 9626811
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
[TBL] [Abstract][Full Text] [Related]
10. A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.
Oikawa T; Murakami K; Sano M; Shibata J; Wierzba K; Yamada Y
Jpn J Cancer Res; 2001 Nov; 92(11):1225-34. PubMed ID: 11714448
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity.
Shibata J; Murakami K; Wierzba K; Aoyagi Y; Hashimoto A; Sano M; Toko T; Yamada Y
Anticancer Res; 2000; 20(5A):3169-76. PubMed ID: 11062739
[TBL] [Abstract][Full Text] [Related]
12. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model.
Ohashi Y; Tsuchiya Y; Koizumi K; Sakurai H; Saiki I
Oncology; 2003; 65(3):250-8. PubMed ID: 14657599
[TBL] [Abstract][Full Text] [Related]
13. A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
Tsuchiya Y; Sawada S; Tsukada K; Saiki I
Int J Oncol; 2002 Feb; 20(2):319-24. PubMed ID: 11788895
[TBL] [Abstract][Full Text] [Related]
14. Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.
Hsieh MJ; Yeh CB; Chiou HL; Hsieh MC; Yang SF
Am J Chin Med; 2016; 44(1):177-95. PubMed ID: 26916922
[TBL] [Abstract][Full Text] [Related]
15. Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.
Ichiki K; Mitani N; Doki Y; Hara H; Misaki T; Saiki I
Clin Exp Metastasis; 2000; 18(7):539-45. PubMed ID: 11688958
[TBL] [Abstract][Full Text] [Related]
16. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
Ezawa S; Suzuki N; Ohie S; Higashiguchi A; Hosoi F; Kitazato K; Susumu N; Aoki D
Gynecol Oncol; 2008 Mar; 108(3):627-31. PubMed ID: 18048092
[TBL] [Abstract][Full Text] [Related]
17. A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.
Suzuki N; Aoki D; Oie S; Horiuchi M; Hasegawa Y; Ezawa S; Suzuki A; Susumu N; Hosoi F; Kitazato K; Nozawa S
Gynecol Oncol; 2004 Sep; 94(3):643-9. PubMed ID: 15350353
[TBL] [Abstract][Full Text] [Related]
18. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor.
Minagawa N; Nakayama Y; Inoue Y; Onitsuka K; Katsuki T; Tsurudome Y; Shibao K; Hirata K; Sako T; Nagata N; Ohie S; Kohno K; Itoh H
Oncol Res; 2004; 14(9):407-14. PubMed ID: 15490972
[TBL] [Abstract][Full Text] [Related]
19. TAC-101, a novel retinobenzoic-acid derivative, enhances gap junctional intercellular communication among renal epithelial cells treated with renal carcinogens.
Miyaguchi T; Nomata K; Noguchi M; Watanabe J; Satoh H; Kanetake H
Anticancer Res; 2001; 21(6A):4025-30. PubMed ID: 11911287
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma.
Sawada S; Murakami K; Yamaura T; Mitani N; Tsukada K; Saiki I
Jpn J Cancer Res; 2002 Feb; 93(2):190-7. PubMed ID: 11856483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
